Pharmacy review for NSW workers' compensation
Managing medication in WorkCover claims and SIRA-regulated schemes
Published: 3 April 2026 | Updated: 3 April 2026
NSW workers' compensation context
NSW workers' compensation operates under the workers' compensation system regulated by SIRA (State Insurance Regulatory Authority). Insurers managing workers' comp claims are responsible for funding treatment, including medication, that's reasonably necessary for the compensable injury. This includes pharmacy costs, which can escalate rapidly on long-term claims.
Your medication management strategy in NSW workers' comp is critical. It protects claimants by ensuring they receive appropriate treatment while protecting your scheme by controlling costs and identifying inefficiencies.
Your position: You're not obligated to fund all medication indefinitely. You're obligated to fund reasonable treatment for the compensable injury. That distinction drives your pharmacy review strategy.
When to refer for a pharmacy review in NSW claims
Consider referring for a pharmacy review when:
- Monthly medication cost exceeds AUD 200: Large invoices warrant scrutiny for duplication, overmedication, or cost optimization opportunities
- Claimant on 5+ medications: Polypharmacy increases interaction risk and inefficiency. A pharmacist can often rationalize regimens
- Long-term benzodiazepines or opioids: These require active monitoring. Pharmacists assess appropriateness, dependency risk, and deprescribing options
- Off-label or expensive medications: When prescriptions fall outside standard evidence-based pathways, pharmacist input clarifies whether funding is justified
- Medication-related adverse effects reported: Side effects blocking rehabilitation need prompt assessment and optimization
- Claim duration exceeds 12 months: Long-term claims often develop medication patterns requiring review and rationalization
What a pharmacy review addresses in NSW context
Clinical assessment
The pharmacist reviews all medications for appropriateness, interactions, and alignment with current clinical needs. Are all medications still needed? Are dosages optimal? Are there safer alternatives? This clinical work protects the claimant and identifies cost-saving opportunities without compromising treatment.
Cost optimization
Pharmacists identify generic alternatives, negotiate with suppliers, and eliminate duplicative medications. In many claims, cost reductions of 30-50% are achievable without reducing clinical benefit. This protects your scheme's costs.
Deprescribing planning
For long-term benzodiazepines, opioids, or other medications with dependence risk, pharmacists design structured deprescribing plans. This transitions claimants to safer, evidence-based therapy while preventing abrupt cessation harms.
Prescriber communication
Pharmacists liaise with prescribers, raising questions about medication choices, suggesting alternatives, and coordinating optimization. This collaborative approach is usually well-received and results in better prescribing.
Claimant education
Pharmacists explain medications, their purpose, side effects, and proper use. Claimants who understand their medications engage better with treatment and are more likely to use them appropriately.
NSW-specific considerations
SIRA expectations
SIRA expects insurers to manage claims efficiently and control costs. Demonstrating active medication management through pharmacist reviews shows regulatory compliance and prudent claim management. Documentation of pharmacy review findings and actions taken protects your insurer position.
Claim closure and medication transition
As NSW claims approach closure (typically at 5 years post-injury), medication funding transitions. Some medications remain under workers' comp (chronic pain, permanent injury consequences). Others transition to the claimant's private health or Medicare. Pharmacist review clarifies which medications are injury-related and appropriate for ongoing workers' comp funding vs. which are general health and appropriate for private/Medicare funding.
Common NSW claim scenarios requiring medication review
Back injury with chronic pain management
Claimants with chronic lower back pain often end up on opioids, benzodiazepines, muscle relaxants, and NSAIDs in combination. Pharmacist review typically identifies: (a) opioid doses that can be reduced while maintaining function; (b) benzodiazepines that should be deprescribed in favor of psychological management; (c) NSAIDs that may be duplicating in different formulations; (d) opportunities to transition to non-pharmacological pain management. These reviews routinely reduce costs by 40-50% while improving claimant function.
Traumatic brain injury with complex polypharmacy
TBI claimants often develop seizure risk (anticonvulsants needed), post-TBI headaches (multiple pain medications), mood changes (antidepressants), and sleep disturbance (sleep aids). Medications accumulate. Pharmacist review clarifies: which anticonvulsants are necessary; whether headache medications are optimized; whether depression/anxiety medications are appropriate and at right doses; whether sleep medication is appropriate or whether sleep hygiene/CBT would be better. This complexity benefits from expert review.
Cumulative trauma disorder with overmedication
Claimants with repetitive strain injuries sometimes develop overlapping treatment from multiple providers. One prescriber adds pain medication, another adds muscle relaxant, a third adds topical agent, a fourth adds supplement. Without coordination, duplication occurs. Pharmacist review identifies redundancy and consolidates to essential medications only.
Cost management in NSW claims
Medication costs are a legitimate claim expense, but they should be controlled. Strategies include:
- Generic prescribing: Request prescribers use generic names, allowing pharmacies to dispense cheaper generics
- PBS listing priority: When multiple medications treat the same condition, prefer PBS-listed options over more expensive alternatives
- Consolidation to one pharmacy: This improves oversight and allows pharmacies to identify and eliminate duplications
- Regular invoice audits: Don't pay without checking. Query large invoices and request itemization
- Structured deprescribing: Long-term medications that are no longer benefiting the claimant should be tapered, reducing ongoing costs
Integration with rehabilitation
In NSW workers' comp, medication management should support rehabilitation, not replace it. A pharmacist review should identify opportunities to transition from medication-dependent pain management to active rehabilitation. For example, reducing opioid doses (which can impair cognition and motivation) while a claimant engages more fully in physiotherapy. Or deprescribing benzodiazepines so a claimant can participate in psychological therapy with better cognitive clarity.
Timeline recommendations
| Claim Stage | Medication Management Focus | When to Review |
|---|---|---|
| Acute phase (0-3 months) | Manage acute symptoms; monitor for side effects; assess appropriateness | If complex polypharmacy or unexpected adverse effects |
| Subacute phase (3-12 months) | Optimize doses; begin deprescribing short-term medications; support rehabilitation | At 6 months to assess progress and plan long-term approach |
| Chronic phase (1-5 years) | Maintain stable, minimal regimen; prevent overmedication; plan transition | Annually or when costs exceed thresholds |
| Pre-closure (approaching 5 years) | Clarify injury-related vs. general health medications; plan transition to private/Medicare | 6 months before anticipated closure |
Documentation for your insurer file
When a pharmacy review is completed, ensure your file includes:
- Referral request and rationale
- Pharmacist report with detailed medication assessment
- Recommendations for medication optimization, cost reduction, or deprescribing
- Cost savings identified
- Actions taken based on recommendations
- Prescriber responses and adjustments made
- Outcome (e.g., medications ceased, doses reduced, costs saved)
This documentation demonstrates active claim management and regulatory compliance.
Working with IMM on NSW claims
IMM specializes in medication reviews for NSW workers' compensation claims. Our process includes:
- Comprehensive medication audit aligned with NSW/SIRA requirements
- Collaboration with treating team and prescribers to optimize medication
- Detailed report with recommendations and cost analysis
- Ongoing support for deprescribing or medication changes
- Regular reassessment as claims evolve
Key takeaways
- Medication review is a practical tool for managing NSW workers' comp claims
- Pharmacist review typically identifies 30-50% cost savings without reducing clinical benefit
- Refer for review when medication costs are high or polypharmacy is complex
- Use reviews to support rehabilitation and reduce medication dependence
- Plan deprescribing for long-term medications before claim closure
- Document medication management for regulatory compliance
Medication costs climbing on your NSW claim?
IMM provides expert medication reviews tailored to NSW workers' compensation. We identify cost savings, optimize therapy, and support deprescribing. Our goal is better claimant outcomes at sustainable cost.
Request a Medication Review
